Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice

Table 2

Composed outcomes of pivotal trials.

	FREEDOMS; 2 years	TRANSFORMS; 1 year
Patients	425	429
Mean follow-up (months)	24	12
Baseline ARR (previous 12 months)	1.5	1.5
Baseline EDSS	2.24	2.2
Free of relapse and EDSS progression	62%	79%
Free of relapse, EDDS progression, and MRI activity	33%	46%